SELL and acute myeloid leukemia: In accordance with our findings, studies by other authors have also reported significantly higher serum L-Selectin levels in patients with ovarian cancer [42], small-cell and non-small-cell lung cancer [43], chronic myelogenic leukemia [44], and acute myeloid leukemia [45] than those in healthy control groups.